Literature DB >> 27685921

Expression profiling of RE1-silencing transcription factor (REST), REST corepressor 1 (RCOR1), and Synapsin 1 (SYN1) genes in human gliomas.

Musteyde Yucebas1, Sunde Yilmaz Susluer, Hasan Onur Caglar, Tugce Balci, Z Ozlem Dogan Sigva, Taner Akalin, Nezih Oktar, Tayfun Dalbasti, Cigir Biray Avci, Cumhur Gunduz.   

Abstract

PURPOSE: The repressor element 1 (RE-1) silencing transcription factor (REST) is a transcription factor which represses the expression of neuronal differentiation-related genes including SYN1 gene. CoREST, encoded by RCOR1 gene, binds to the REST protein for remodeling of chromatin structure. Although there is a relation among REST, RCOR1, and SYN1 genes, the role of these genes in glioma tumors is still unclear. In this study, expressions of REST, RCOR1, and SYN1 genes were detected in primary cultures derived from tumor samples of diffuse astrocytoma (DA), anaplastic oligodendroglioma (AO), and glioblastoma multiforme (GBM) cases.
METHODS: Expression profiles were analysed by RT-qPCR and the copy number variations were examined with qPCR in primary cultures. ChIP assay was performed to show binding characteristics of REST and CoREST proteins on promoter region of SYN1 gene.
RESULTS: Means of relative expression for REST were as follows: 0.7898, 0.7606, and 0.7318 in DA, AO, and GBM groups, respectively. For RCOR1, expression means in DA, AO, and GBM groups were 0.7203, 0.7334, and 0.7230, respectively. SYN1 expression means were as follows: 0.3936, 0.3192, and 0.3197 in DA, AO, and GBM groups, respectively. Neither gain nor loss of copy numbers were detected for REST and RCOR1 genes in all groups. Copy loss for SYN1 was detected in primary culture of a DA case. REST and CoREST presented positive precipitation pattern on promoter region of SYN1 gene.
CONCLUSIONS: Expressions of REST and RCOR1 genes may downregulate SYN1 expression in gliomas. Low expression pattern of SYN1 may maintain cancer stem-like phenotype which contributes to development of gliomas.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27685921

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  4 in total

1.  Identification of hub genes and small-molecule compounds in medulloblastoma by integrated bioinformatic analyses.

Authors:  Zhendong Liu; Ruotian Zhang; Zhenying Sun; Jiawei Yao; Penglei Yao; Xin Chen; Xinzhuang Wang; Ming Gao; Jinzhao Wan; Yiming Du; Shiguang Zhao
Journal:  PeerJ       Date:  2020-04-14       Impact factor: 2.984

2.  Hub genes for early diagnosis and therapy of adamantinomatous craniopharyngioma.

Authors:  Yang-Fan Zou; Shu-Yuan Zhang; Li-Weng Li; Kai Jing; Liang Xia; Cai-Xing Sun; Bin Wu
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

3.  Development and Validation of a Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Low-Grade Gliomas.

Authors:  Lidong Ning; Guanyan Zhao; Changji Xie; Huan Lan; Jiefei Chen; Hu Tan; ChengCong Wei; Zhiyu Zhou
Journal:  Dis Markers       Date:  2022-09-23       Impact factor: 3.464

4.  Risk score based on three mRNA expression predicts the survival of bladder cancer.

Authors:  Qingzuo Liu; Ruigang Diao; Guoyan Feng; Xiaodong Mu; Aiqun Li
Journal:  Oncotarget       Date:  2017-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.